Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# # robots.txt # # This file is to prevent the crawling and indexing of certain parts # of your site by web crawlers and spiders run by sites like Yahoo! # and Google. By telling these "robots" where not to go on your site, # you save bandwidth and server resources. # # This file will be ignored unless it is at the root of your host: # Used: http://example.com/robots.txt # Ignored: http://example.com/site/robots.txt # # For more information about the robots.txt standard, see: # http://www.robotstxt.org/robotstxt.html User-agent: * Crawl-delay: 10 # CSS, JS, Images Allow: /misc/*.css$ Allow: /misc/*.css? Allow: /misc/*.js$ Allow: /misc/*.js? Allow: /misc/*.gif Allow: /misc/*.jpg Allow: /misc/*.jpeg Allow: /misc/*.png Allow: /modules/*.css$ Allow: /modules/*.css? Allow: /modules/*.js$ Allow: /modules/*.js? Allow: /modules/*.gif Allow: /modules/*.jpg Allow: /modules/*.jpeg Allow: /modules/*.png Allow: /profiles/*.css$ Allow: /profiles/*.css? Allow: /profiles/*.js$ Allow: /profiles/*.js? |
Title | RYBREVANT® for EGFR+ mNSCLC | RYBREVANT® |
Description | Sorry, you need to enable JavaScript to visit this The official patient website for RYBREVANT® (amivantamab-vmjw) for the treatment of mNSCLC with EGFR Exon 20 insertion mutations. See Full Prescribing & Safety |
Keywords | N/A |
WebSite | rybrevant.com |
Host IP | 104.18.19.144 |
Location | United States |
Site | Rank |
US$11,534,944
Last updated: 2023-05-09 10:59:45
rybrevant.com has Semrush global rank of 917,586. rybrevant.com has an estimated worth of US$ 11,534,944, based on its estimated Ads revenue. rybrevant.com receives approximately 1,330,956 unique visitors each day. Its web server is located in United States, with IP address 104.18.19.144. According to SiteAdvisor, rybrevant.com is safe to visit. |
Purchase/Sale Value | US$11,534,944 |
Daily Ads Revenue | US$10,648 |
Monthly Ads Revenue | US$319,430 |
Yearly Ads Revenue | US$3,833,151 |
Daily Unique Visitors | 88,731 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
rybrevant.com. | A | 1800 | IP: rybrevant.com.cdn.cloudflare.net. |
rybrevant.com.cdn.cloudflare.net. 299 IN A | A | IP: 104.18.19.144 | |
rybrevant.com.cdn.cloudflare.net. 299 IN A | A | IP: 104.18.18.144 | |
rybrevant.com. | AAAA | 1799 | IPV6: rybrevant.com.cdn.cloudflare.net. |
rybrevant.com.cdn.cloudflare.net. 300 IN AAAA | AAAA | IPV6: 2606:4700::6812:1390 | |
rybrevant.com.cdn.cloudflare.net. 300 IN AAAA | AAAA | IPV6: 2606:4700::6812:1290 | |
rybrevant.com. | NS | 1800 | NS Record: ns1.jnj.com. |
rybrevant.com. | NS | 1800 | NS Record: ns5.jnj.com. |
rybrevant.com. | NS | 1800 | NS Record: ns3.jnj.com. |
Patient Information RYBREVANT ® Prescribing Information RYBREVANT ® Información de Prescripción RYBREVANT ® 處方信息 Important Safety Information For US Healthcare Providers Contact Janssen Register for Updates Prescribing Information For US Healthcare Providers Register for Updates Toggle navigation Register for Updates Prescribing Information About EGFR Exon 20 What Is RYBREVANT ® How RYBREVANT ® Is Given Paying for RYBREVANT ® Tips & Tools Important Safety Information Patient Information RYBREVANT ® Prescribing Information RYBREVANT ® Información de Prescripción RYBREVANT ® 處方信息 Contact Janssen For US Healthcare Providers Treat metastatic non–small cell lung cancer (mNSCLC) with epidermal growth factor receptor ( EGFR ) exon 20 insertion mutations after chemotherapy that contains platinum. RYBREVANT ® is the first and only antibody treatment designed to target mNSCLC with EGFR exon 20 insertion mutations 40% of people treated with RYBREVANT ® after chemotherapy that contains platinum |
HTTP/1.1 301 Moved Permanently Date: Sun, 31 Oct 2021 18:13:01 GMT Content-Type: text/html Connection: keep-alive Location: https://rybrevant.com/ Strict-Transport-Security: max-age=0 X-Debug-Info: eyJyZXRyaWVzIjowfQ== X-Platform-Cluster: g5bg3t7qbvpjo-master-7rqtwti X-Platform-Router: eaxwouplkuqw6gn463hutioi7m X-Request-Id: 00-16b3299437b2812413755dab51d41a56-46e5e17f5af56366-00 CF-Cache-Status: HIT Age: 7175 Server: cloudflare CF-RAY: 6a6edadb6daf2d88-ORD HTTP/2 301 date: Sun, 31 Oct 2021 18:13:01 GMT content-type: text/html location: https://www.rybrevant.com/ strict-transport-security: max-age=0 x-debug-info: eyJyZXRyaWVzIjowfQ== x-platform-cluster: g5bg3t7qbvpjo-master-7rqtwti x-platform-router: eaxwouplkuqw6gn463hutioi7m x-request-id: 00-16b32f09463390447edfc510fe4e84e1-8350f34a29e0661f-00 cf-cache-status: HIT age: 1175 expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 6a6edadbde226348-ORD HTTP/2 200 date: Sun, 31 Oct 2021 18:13:01 GMT content-type: text/html cache-control: max-age=86400 expires: Mon, 01 Nov 2021 00:22:27 GMT last-modified: Sun, 15 Aug 2021 11:26:40 GMT strict-transport-security: max-age=0 vary: Accept-Encoding x-debug-info: eyJyZXRyaWVzIjowfQ== x-frame-options: SAMEORIGIN x-platform-cluster: g5bg3t7qbvpjo-master-7rqtwti x-platform-processor: ku3mb6wzyl3l3ilgcxjib7a3vq x-platform-router: eaxwouplkuqw6gn463hutioi7m x-request-id: 00-16a7a53bd1eb01691dbf8c3bb7d47d0e-9b3d087cf0fafee9-00 cf-cache-status: HIT age: 64234 expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 6a6edaddd9ce6393-ORD |
Domain Name: RYBREVANT.COM Registry Domain ID: 2430162139_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.rrpproxy.net Registrar URL: http://www.key-systems.net Updated Date: 2021-08-05T03:00:27Z Creation Date: 2019-09-05T15:57:43Z Registry Expiry Date: 2022-09-05T15:57:43Z Registrar: Key-Systems GmbH Registrar IANA ID: 269 Registrar Abuse Contact Email: abuse@key-systems.net Registrar Abuse Contact Phone: +49.68949396850 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.JNJ.COM Name Server: NS3.JNJ.COM Name Server: NS5.JNJ.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-19T03:55:24Z <<< |